119 related articles for article (PubMed ID: 37995775)
1. Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis.
Seco-Cervera M; Ortiz-Masiá D; Macias-Ceja DC; Coll S; Gisbert-Ferrándiz L; Cosín-Roger J; Bauset C; Ortega M; Heras-Morán B; Navarro-Vicente F; Millán M; Esplugues JV; Calatayud S; Barrachina MD
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166966. PubMed ID: 37995775
[TBL] [Abstract][Full Text] [Related]
2. Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis.
Masterson JC; Capocelli KE; Hosford L; Biette K; McNamee EN; de Zoeten EF; Harris R; Fernando SD; Jedlicka P; Protheroe C; Lee JJ; Furuta GT
Inflamm Bowel Dis; 2015 Oct; 21(10):2429-40. PubMed ID: 26218140
[TBL] [Abstract][Full Text] [Related]
3. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts.
Johnson LA; Rodansky ES; Sauder KL; Horowitz JC; Mih JD; Tschumperlin DJ; Higgins PD
Inflamm Bowel Dis; 2013 Apr; 19(5):891-903. PubMed ID: 23502354
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1.
Yu M; Zhu W; Wang J; Chen X; He X; Lin B; Cen L; Zhou T; Lu C; Yu C; Sun J
Inflamm Bowel Dis; 2022 Jun; 28(6):923-935. PubMed ID: 35020883
[TBL] [Abstract][Full Text] [Related]
5. MCL-1 is modulated in Crohn's disease fibrosis by miR-29b via IL-6 and IL-8.
Nijhuis A; Curciarello R; Mehta S; Feakins R; Bishop CL; Lindsay JO; Silver A
Cell Tissue Res; 2017 May; 368(2):325-335. PubMed ID: 28190086
[TBL] [Abstract][Full Text] [Related]
6. Cadherin-11 Is a Regulator of Intestinal Fibrosis.
Franzè E; Monteleone I; Laudisi F; Rizzo A; Dinallo V; Di Fusco D; Colantoni A; Ortenzi A; Giuffrida P; Di Carlo S; Sica GS; Di Sabatino A; Monteleone G
J Crohns Colitis; 2020 Mar; 14(3):406-417. PubMed ID: 31504344
[TBL] [Abstract][Full Text] [Related]
7. Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.
Lian L; Huang Q; Zhang L; Qin H; He X; He X; Ke J; Xie M; Lan P
Dig Dis Sci; 2018 Jul; 63(7):1821-1834. PubMed ID: 29704139
[TBL] [Abstract][Full Text] [Related]
8. Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease.
Ngoh EN; Weisser SB; Lo Y; Kozicky LK; Jen R; Brugger HK; Menzies SC; McLarren KW; Nackiewicz D; van Rooijen N; Jacobson K; Ehses JA; Turvey SE; Sly LM
Gastroenterology; 2016 Feb; 150(2):465-76. PubMed ID: 26481854
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin is overexpressed in Crohn's stricture fibroblasts and promotes intestinal fibroblast migration.
Burke JP; Cunningham MF; Sweeney C; Docherty NG; O'Connell PR
Inflamm Bowel Dis; 2011 Aug; 17(8):1665-73. PubMed ID: 21287659
[TBL] [Abstract][Full Text] [Related]
10. Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's disease.
Beddy DJ; Watson WR; Fitzpatrick JM; O'Connell PR
J Am Coll Surg; 2004 Aug; 199(2):234-42. PubMed ID: 15275879
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
[TBL] [Abstract][Full Text] [Related]
12. T-cell Composition in Ileal and Colonic Creeping Fat - Separating Ileal from Colonic Crohn's Disease.
Kredel LI; Jödicke LJ; Scheffold A; Gröne J; Glauben R; Erben U; Kühl AA; Siegmund B
J Crohns Colitis; 2019 Jan; 13(1):79-91. PubMed ID: 30272118
[TBL] [Abstract][Full Text] [Related]
13. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
14. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration.
Cunningham MF; Docherty NG; Burke JP; O'Connell PR
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G457-66. PubMed ID: 20489045
[TBL] [Abstract][Full Text] [Related]
15. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
[TBL] [Abstract][Full Text] [Related]
17. Altered Expression of Angiotensinogen and Mediators of Angiogenesis in Ileal Crohn's Disease.
Hume GE; Doecke JD; Huang N; Fowler EV; Brown IS; Simms LA; Radford-Smith GL
J Gastrointestin Liver Dis; 2016 Mar; 25(1):39-48. PubMed ID: 27014752
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
[TBL] [Abstract][Full Text] [Related]
19. A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients.
Li Yim AYF; de Bruyn JR; Duijvis NW; Sharp C; Ferrero E; de Jonge WJ; Wildenberg ME; Mannens MMAM; Buskens CJ; D'Haens GR; Henneman P; Te Velde AA
PLoS One; 2018; 13(12):e0209656. PubMed ID: 30589872
[TBL] [Abstract][Full Text] [Related]
20. TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn's disease.
Grillo AR; Scarpa M; D'Incà R; Brun P; Scarpa M; Porzionato A; De Caro R; Martines D; Buda A; Angriman I; Palù G; Sturniolo GC; Castagliuolo I
Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(6):G443-54. PubMed ID: 26185333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
